Dap-ug, Jellfe E.

HRN: 22-12-30  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/26/2023
CEFUROXIME 1.5GM (VIAL)
11/26/2023
11/27/2023
IV
1.5gms
PTOR
For Stat CS
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: